Medline is looking to broaden its business with hospitals and grow through acquisitions after capping 2025 with the year’s ...
Investor's Business Daily on MSN
Medline sees RS rating climb to 77
Medline shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...
・Medline plans to sell 179 million Class A shares at $26 to $30 each. ・Major institutional investors signaled interest in buying as much as $2.35 billion of stock. ・Proceeds will be used to buy units ...
Being public gives the company a very attractive cost of capital currency to go and think creatively about what future deals ...
The listing will overshadow the $5.3 billion raised in May by Chinese battery company Contemporary Amperex Technology Co, known as CATL, the Financial Times reported. (Image: X) Medline Inc. has ...
Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026. A press release and supplemental ...
Medline shares close 41% above offer price in debut Tariffs pose a challenge for Medline SpaceX, others eye 2026 listing Dec 17 (Reuters) - Medical supply giant Medline's shares rose 41% above their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results